<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05087394</url>
  </required_header>
  <id_info>
    <org_study_id>COVIDPas1</org_study_id>
    <nct_id>NCT05087394</nct_id>
  </id_info>
  <brief_title>COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina)</brief_title>
  <acronym>COVIDPas</acronym>
  <official_title>Cohort of COVID19 Patients Admitted to Pasteur Clinic 2020-2021</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociacion Latinoamericana de Torax</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asociacion Latinoamericana de Torax</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      retrospective cohort (non-experimental study) of COVID 19 patients assisted in&#xD;
      hospitalization (severe and critical) between 2020 and 2021&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients with acute infection by SARS-COV2 and severe or critical COVID19&#xD;
      disease, or acute complications, hospitalized in the Pasteur Clinic of Neuquén city from the&#xD;
      beginning of the pandemic in the region until December 31, 2021. Data were obtained&#xD;
      retrospectively from information registered simultaneously with hospitalization in three&#xD;
      databases (RedCap, DataTech and Excel).&#xD;
&#xD;
      . Inclusion criteria&#xD;
&#xD;
        -  Adult patients (over 18 years old)&#xD;
&#xD;
        -  Suffering from acute infection by SARS-Cov2, diagnosed by PCR-real time, detection of&#xD;
           viral antigen, specific antibodies with or clinical epidemiological criteria&#xD;
&#xD;
        -  Hospitalized defined by attending physicians or referral (severe or critical according&#xD;
           to NIH) Exclusion criteria&#xD;
&#xD;
        -  Patients under 18 years of age.&#xD;
&#xD;
        -  Convalescent from acute SARS-Cov2 infection and without evidence of a new event of&#xD;
           reinfection.&#xD;
&#xD;
        -  Outpatient management or hospitalization less than 24 hours for diagnosis and / or&#xD;
           evaluation of severity or complications. Sample Selection Method First patient was&#xD;
           registered at the beginning of the pandemic in the region March 20, 2020) and is&#xD;
           expected to recruit the las patient diagnosed in December 31, 2021.&#xD;
&#xD;
      The recruitment is consecutive without other selection criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Anticipated">January 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>From date of admition until the date of death from any cause, assessed up to 28 day</time_frame>
    <description>defined as death ocurred within 28 days of admition to hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>From date of admition until the date of death from any cause, assessed up to 52 weeks</time_frame>
    <description>defined as death ocurred within hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Invasive Mechanical ventilation</measure>
    <time_frame>From date of admition until the date of equirement of invasive mechanical ventilation, assessed up to 21 day</time_frame>
    <description>defined as requirement of invasive mechanical ventilation support</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>COVID-19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comorbidities</intervention_name>
    <description>Risk factors (comorbidities), requirements of respiratory suppot and chest imaging will are considered exposure for primary outcomes</description>
    <other_name>Oxigen requirement</other_name>
    <other_name>Mechanical Ventilation</other_name>
    <other_name>High flow nasal cannula</other_name>
    <other_name>Chest CT scan</other_name>
    <other_name>CT pulmonary angiogram (CTPA)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with severe or critical (according to NIH) COVID19 diseased admitted to&#xD;
        Pasteur Clinic in 202 and 2021&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (over 18 years old)&#xD;
&#xD;
          -  Suffering from acute infection by SARS-Cov2, diagnosed by PCR-real time, detection of&#xD;
             viral antigen, specific antibodies with or clinical epidemiological criteria&#xD;
&#xD;
          -  Hospitalization defined by attending or referral physician (severe or critical&#xD;
             according to NIH)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years of age.&#xD;
&#xD;
          -  Convalescent from acute SARS-Cov2 infection and without evidence of a new event&#xD;
             reinfection.&#xD;
&#xD;
          -  Outpatient management or hospitalization less than 24 hours for diagnosis and / or&#xD;
             evaluation of severity or complications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo Zabert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Pasteur</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ignacio Zabert, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinica Pasteur</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ignacio Veltri, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinica Pasteur</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gustavo E Zabert, MD</last_name>
    <phone>+5492994063992</phone>
    <email>gzabert@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ignacio Veltri, MD</last_name>
    <phone>+5492994109860</phone>
    <email>igveltri@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pasteur Clinic</name>
      <address>
        <city>Neuquen</city>
        <state>Nqn</state>
        <zip>8300</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo E Zabert, MD</last_name>
      <phone>299154063992</phone>
      <email>gzabert@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ignacio Veltri, MD</last_name>
      <phone>+541154843128</phone>
      <email>igveltri@gmial.com</email>
    </contact_backup>
    <investigator>
      <last_name>Fabian Mariluan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucio Espinosa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nelson Fernandez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcela Santini, Lic</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcelo Alonso, Lic</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liliana Calanni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Facundo Goya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carolina Pincheira, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <link>
    <url>https://drive.google.com/drive/u/0/folders/1BK1rSlpCR2KzydRxRp6KKUsqLezIKsAi</url>
    <description>Documento de Comité Asesor de Ética de La Clínica Pasteur Para La Implementación Del Documento de Aspectos Éticos En La Pandemia de COVID19 En El Escenario de Recursos Escasos. Neuquen; 2020</description>
  </link>
  <reference>
    <citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.</citation>
    <PMID>32109013</PMID>
  </reference>
  <reference>
    <citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.</citation>
    <PMID>32091533</PMID>
  </reference>
  <reference>
    <citation>Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.</citation>
    <PMID>32167538</PMID>
  </reference>
  <reference>
    <citation>Redondo-Bravo L, Moros MJS, Sanchez EVM, et al. The first wave of the COVID-19 pandemic in Spain: Characterisation of cases and risk factors for severRedondo-Bravo, L., Moros, M. J. S., Sanchez, E. V. M., Lorusso, N., Ubago, A. C., Garcia, V. G., Villanueva, P. S., Azon, A. P., Bescos, J. G., Boone, A. Eurosurveillance. 2020;25(50):1-13.</citation>
  </reference>
  <reference>
    <citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.</citation>
    <PMID>32171076</PMID>
  </reference>
  <reference>
    <citation>Aylward L, Liang W, Dong X, et al., World Health Organization W. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO-China Jt Mission Coronavirus Dis 2019. 2020;1(16-24 February):1-40.</citation>
  </reference>
  <reference>
    <citation>Lamfre L, Caro P, Hasdeu S, Horne F. Modelo de Proyección de Casos Esperados COVID-19 En Argentina 2020. Neuquen https://1331c255-c873-472c-8edd- 6738111a6c38.filesusr.com/ugd/d623b6_007bc0ad0898495882e61367e1d2644d.pdf.</citation>
  </reference>
  <reference>
    <citation>Espinosa L, Ambort C, Vera M, et al. Documento de Comité Asesor de Ética de La Clínica Pasteur Para La Implementación Del Documento de Aspectos Éticos En La Pandemia de COVID19 En El Escenario de Recursos Escasos. Neuquen; 2020. https://drive.google.com/drive/u/0/folders/1BK1rSlpCR2KzydRxRp6KKUsqLezIKsAi</citation>
  </reference>
  <reference>
    <citation>MSal Neuquen. ASPECTOS ÉTICOS EN LA ATENCIÓN DE LAS PERSONAS DURANTE LA PANDEMIA POR CORONAVIRUS ( SARS-CoV-2 ). Neuquen; 2020.</citation>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asociacion Latinoamericana de Torax</investigator_affiliation>
    <investigator_full_name>Gustavo Zabert, MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>at the end of the study or at specific requirements</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

